Leerink Partners analyst Mike Kratky downgrades Axonics (NASDAQ:AXNX) from Outperform to Market Perform and announces $71 price target.
Leerink Partners Downgrades Axonics to Market Perform, Announces $71 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.